Liver Diseases  >>  Tyzeka (telbivudine)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tyzeka (telbivudine) / Novartis
NCT00124241: An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

Completed
2b
US, Canada, Europe, RoW
telbivudine, lamivudine
Novartis, Novartis Pharmaceuticals
Hepatitis B
02/03
11/05
NCT00128544: Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Completed
2b
130
RoW
telbivudine, valtorcitabine
Novartis, Novartis Pharmaceuticals
Hepatitis B
05/07
05/07
NCT00804622: Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Completed
2
15
RoW
telbivudine, tenofovir disproxil fumarate, telbivudine plus tenofovir disproxil fumarate
The University of Hong Kong, Novartis Pharmaceuticals
Chronic Hepatitis B
06/09
03/10
NCT02338674: TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction

Completed
1/2
121
RoW
Tenofovir and telbivudine, combination therapy, Tenofovir, single therapy
Fuzhou General Hospital
Hepatitis B, Chronic
10/16
10/17

Download Options